A GLP-1 that is not an injectable could transform the diabetes and weight loss drug boom.
#stockmarket #breaking
GLP-1 pill: Eli Lilly says its oral orforglipron showing “promising results” – Axios
Related Posts
Markets brace for presidential election, Fed meeting: What to know this week – Yahoo Finance
None #stockmarket #breaking
Citadel Securities Warns SEC That Private Rooms, 24-Hour Trading Are Emerging Risks – Bloomberg.com
Citadel Securities is urging the Securities and Exchange Commission’s new leadership to examine a list of what it argues are…
